About

Dr. Jens Bedke is a leading urologic surgeon and researcher whose work centers on advancing prostate and kidney cancer diagnostics and treatment through precision imaging and robotic surgery. His major contributions lie in refining prostate cancer detection, particularly for patients with prior negative biopsies. He has pioneered the evaluation of cognitive, robotic, and in-bore MRI-targeted biopsy techniques, demonstrating their superiority over systematic approaches, with his landmark 2018 study garnering 48 citations. Dr. Bedke has also been instrumental in validating biparametric MRI as a viable alternative to multiparametric MRI for guiding fusion biopsies, and in exploring novel imaging methods like T2 mapping and computed tomographic ultrasound with artificial neural network analysis to characterize prostate lesions. Beyond diagnostics, he has made significant strides in surgical technique, leading the randomized OpeRa trial (2025, 12 citations) comparing open versus robotic-assisted partial nephrectomy for complex kidney tumors, and contributing to EAU guidelines on live surgery and telesurgery. His work, cited over 200 times, consistently pushes the boundaries of minimally invasive, image-guided urologic oncology, making him a pivotal figure in the field.

Research Focus

Key Achievements

8
H-Index
11
Papers
200
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy
48 citations · 2018
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 60
🏛 Institutions: University of Tübingen, Universitätsklinikum Tübingen, University Children's Hospital Tübingen, Klinikum Stuttgart

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago